Semin Neurol 2018; 38(05): 515-521
DOI: 10.1055/s-0038-1667383
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Ethical Issues in Vascular Neurology

Natalie C. Wheeler
1   Department of Neurology, University of Wisconsin, Madison, Wisconsin
,
Sadhana Murali
1   Department of Neurology, University of Wisconsin, Madison, Wisconsin
,
Justin A. Sattin
1   Department of Neurology, University of Wisconsin, Madison, Wisconsin
› Author Affiliations
Further Information

Publication History

Publication Date:
15 October 2018 (online)

Abstract

There are ethical aspects to each of the three phases of cerebrovascular disease: hyperacute management, acute prognostication and management of early complications, and long-term recovery and reintegration with the community. This article addresses ethical concerns pertinent to each phase. First, we discuss ethical issues regarding consent for thrombolysis and endovascular treatment for acute ischemic stroke, including a review of considerations regarding the provision of acute stroke treatment advice over the telephone. Next, we discuss capacity for consent and prognostication after ischemic stroke and intracranial hemorrhage, with a focus on the problems of the self-fulfilling prophecy. Finally, we discuss residual disability and patients' return to driving. Consideration of these ethical dimensions of cerebrovascular disease will assist neurologists in caring for patients and families suffering from this complex condition.

 
  • References

  • 1 Benjamin EJ, Virani SS, Callaway CW. , et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2018 Update: a report from the American Heart Association. Circulation 2018; 137 (12) e67-e492
  • 2 Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 7th ed. New York: Oxford University Press; 2013
  • 3 National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333 (24) 1581-1587
  • 4 Hacke W, Donnan G, Fieschi C. , et al; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363 (9411): 768-774
  • 5 Murtagh MJ, Burges Watson DL, Jenkings KN. , et al. Situationally-sensitive knowledge translation and relational decision making in hyperacute stroke: a qualitative study. PLoS One 2012; 7 (06) e37066
  • 6 Buchan AM, Barber PA, Newcommon N. , et al. Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Neurology 2000; 54 (03) 679-684
  • 7 Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurrú C, Biller J. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke 2001; 32 (01) 12-16
  • 8 Lyerly MJ, Albright KC, Boehme AK. , et al. Safety of protocol violations in acute stroke tPA administration. J Stroke Cerebrovasc Dis 2014; 23 (05) 855-860
  • 9 American Academy of Neurology. Policy on Consent Issues for the Administration of IV tPA. Available at: http://buyabrain.net/globals/axon/assets/8847.pdf . Accessed March 11, 2018
  • 10 Powers WJ, Derdeyn CP, Biller J. , et al; American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46 (10) 3020-3035
  • 11 Albers GW, Marks MP, Kemp S. , et al; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378 (08) 708-718
  • 12 Nogueira RG, Jadhav AP, Haussen DC. , et al; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378 (01) 11-21
  • 13 Sattin JA. Telephone consultations for tissue plasminogen activator administration in acute stroke. Continuum (Minneap Minn) 2014; 20 (2 Cerebrovascular Disease): 429-435
  • 14 Meyer BC, Raman R, Hemmen T. , et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol 2008; 7 (09) 787-795
  • 15 Chen Y, Bogosavljevic V, Leys D, Jovanovic D, Beslac-Bumbasirevic L, Lucas C. Intravenous thrombolytic therapy in patients with stroke mimics: baseline characteristics and safety profile. Eur J Neurol 2011; 18 (10) 1246-1250
  • 16 Zinkstok SM, Engelter ST, Gensicke H. , et al. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke 2013; 44 (04) 1080-1084
  • 17 Olick RS, Bergus GR. Malpractice liability for informal consultations. Fam Med 2003; 35 (07) 476-481
  • 18 Appelbaum PS. Clinical practice. Assessment of patients' competence to consent to treatment. N Engl J Med 2007; 357 (18) 1834-1840
  • 19 Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions. Psychiatr Serv 1997; 48 (11) 1415-1419
  • 20 Marson DC, Ingram KK, Cody HA, Harrell LE. Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument. Arch Neurol 1995; 52 (10) 949-954
  • 21 Wilks I. The debate over risk-related standards of competence. Bioethics 1997; 11 (05) 413-426
  • 22 The Patient Self Determination Act, Pub. L. No. 101–508, §§4206 & 4751, 104 Stat. 1388 (codified in 42 USC §§ 1395cc(f), 1396a(w) (1994))
  • 23 Fried TR, Zenoni M, Iannone L, O'Leary J, Fenton BT. Engagement in advance care planning and surrogates' knowledge of patients' treatment goals. J Am Geriatr Soc 2017; 65 (08) 1712-1718
  • 24 Downey L, Au DH, Curtis JR, Engelberg RA. Life-sustaining treatment preferences: matches and mismatches between patients' preferences and clinicians' perceptions. J Pain Symptom Manage 2013; 46 (01) 9-19
  • 25 Winter L, Parks SM, Diamond JJ. Ask a different question, get a different answer: why living wills are poor guides to care preferences at the end of life. J Palliat Med 2010; 13 (05) 567-572
  • 26 Lackland DT, Roccella EJ, Deutsch AF. , et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; Council on Functional Genomics and Translational Biology. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 2014; 45 (01) 315-353
  • 27 Zahuranec DB, Morgenstern LB, Sánchez BN, Resnicow K, White DB, Hemphill III JC. Do-not-resuscitate orders and predictive models after intracerebral hemorrhage. Neurology 2010; 75 (07) 626-633
  • 28 Kelly AG, Hoskins KD, Holloway RG. Early stroke mortality, patient preferences, and the withdrawal of care bias. Neurology 2012; 79 (09) 941-944
  • 29 Morgenstern LB, Zahuranec DB, Sánchez BN. , et al. Full medical support for intracerebral hemorrhage. Neurology 2015; 84 (17) 1739-1744
  • 30 Zahuranec DB, Brown DL, Lisabeth LD. , et al. Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology 2007; 68 (20) 1651-1657
  • 31 Hemphill III JC, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke 2004; 35 (05) 1130-1134
  • 32 Hemphill III JC, Greenberg SM, Anderson CS. , et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46 (07) 2032-2060
  • 33 Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002; 346 (14) 1061-1066
  • 34 Hanger HC, Fogarty B, Wilkinson TJ, Sainsbury R. Stroke patients' views on stroke outcomes: death versus disability. Clin Rehabil 2000; 14 (04) 417-424
  • 35 Albrecht GL, Devlieger PJ. The disability paradox: high quality of life against all odds. Soc Sci Med 1999; 48 (08) 977-988
  • 36 Kiphuth IC, Köhrmann M, Kuramatsu JB. , et al. Retrospective agreement and consent to neurocritical care is influenced by functional outcome. Crit Care 2010; 14 (04) R144
  • 37 Holloway RG, Benesch CG, Burgin WS, Zentner JB. Prognosis and decision making in severe stroke. JAMA 2005; 294 (06) 725-733
  • 38 Holloway RG, Arnold RM, Creutzfeldt CJ. , et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology. Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45 (06) 1887-1916
  • 39 Anstey KJ, Wood J, Lord S, Walker JG. Cognitive, sensory and physical factors enabling driving safety in older adults. Clin Psychol Rev 2005; 25 (01) 45-65
  • 40 Devos H, Akinwuntan AE, Nieuwboer A, Truijen S, Tant M, De Weerdt W. Screening for fitness to drive after stroke: a systematic review and meta-analysis. Neurology 2011; 76 (08) 747-756
  • 41 Marshall SC, Molnar F, Man-Son-Hing M. , et al. Predictors of driving ability following stroke: a systematic review. Top Stroke Rehabil 2007; 14 (01) 98-114
  • 42 Winstein CJ, Stein J, Arena R. , et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2016; 47 (06) e98-e169
  • 43 American Medical Association. Declaration of Professional Responsibility. 2000: 144–45 in Code of Medical Ethics 2000–2001 Edition xiv. Chicago, IL: American Medical Association;
  • 44 Department of Health & Human Services Aging and Disability Services Division. Quick Facts Regarding Cognitive Impairment and Age Related License Restrictions. Available at: http://adsd.nv.gov/uploadedFiles/adsdnvgov/content/Boards/TaskForceAlzheimers/StateRegulationsDementiaandDriving.pdf . Accessed March 13, 2018
  • 45 Berger JT, Rosner F, Kark P, Bennett AJ. ; The Committee on Bioethical Issues of the Medical Society of the State of New York. Reporting by physicians of impaired drivers and potentially impaired drivers. J Gen Intern Med 2000; 15 (09) 667-672
  • 46 Bacon D, Fisher RS, Morris JC, Rizzo M, Spanaki MV. American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence. Neurology 2007; 68 (15) 1174-1177